- Home
- GIG vs BLDE Comparison
GIG vs BLDE Comparison
Compare GIG & BLDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GIG
- BLDE
- Stock Information
- Founded
- GIG 2024
- BLDE 2014
- Country
- GIG United States
- BLDE United States
- Employees
- GIG N/A
- BLDE N/A
- Industry
- GIG
- BLDE Aerospace
- Sector
- GIG
- BLDE Consumer Discretionary
- Exchange
- GIG NYSE
- BLDE Nasdaq
- Market Cap
- GIG 343.0M
- BLDE 286.0M
- IPO Year
- GIG 2024
- BLDE N/A
- Fundamental
- Price
- GIG $10.34
- BLDE $3.80
- Analyst Decision
- GIG
- BLDE Strong Buy
- Analyst Count
- GIG 0
- BLDE 2
- Target Price
- GIG N/A
- BLDE $6.25
- AVG Volume (30 Days)
- GIG 21.7K
- BLDE 660.7K
- Earning Date
- GIG 01-01-0001
- BLDE 05-12-2025
- Dividend Yield
- GIG N/A
- BLDE N/A
- EPS Growth
- GIG N/A
- BLDE N/A
- EPS
- GIG 0.10
- BLDE N/A
- Revenue
- GIG N/A
- BLDE $251,485,000.00
- Revenue This Year
- GIG N/A
- BLDE $5.58
- Revenue Next Year
- GIG N/A
- BLDE $8.40
- P/E Ratio
- GIG $99.07
- BLDE N/A
- Revenue Growth
- GIG N/A
- BLDE 8.67
- 52 Week Low
- GIG $9.89
- BLDE $2.35
- 52 Week High
- GIG $10.38
- BLDE $5.17
- Technical
- Relative Strength Index (RSI)
- GIG N/A
- BLDE 67.34
- Support Level
- GIG N/A
- BLDE $3.51
- Resistance Level
- GIG N/A
- BLDE $3.69
- Average True Range (ATR)
- GIG 0.00
- BLDE 0.17
- MACD
- GIG 0.00
- BLDE 0.00
- Stochastic Oscillator
- GIG 0.00
- BLDE 90.74
About GIG GIGCAPITAL7 CORP.
GigCapital7 Corp is a Private-to-Public Equity (PPE) company, also known as a blank check company or special purpose acquisition company.
About BLDE Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.